Created with. ASX - General. boolish Jellyroll hey. . Created with Sketch. 0 Million. I'm topping up. 91%) As of 03:35PM EST. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. 3¢. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - By Stock. What would you like to pay the world leader in IIH science as CSO, and how much of that salary you would expect to be spent on market to buy shares? Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself, Publication of Invex IIH Phase II Pressure Trial Results. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. 0% $ODM 35. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. ASX - Day TradingCreated with Sketch. . Lucky for you all IXC still sits at only 60 cents. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. 5% last year. 26 area could be wrong and it could go for example to $3. Appendix 4E and Annual Report, page-2. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Forums. Latest Posts. ASX - General. . Although, IXC is trading about 3-4x lower than what I expect it to be. Charts. IXC Price at posting: 37. . ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. ASX - Short Term Trading. Invex Receives Approval for Paediatric Plan from the EMA, page-2. Advertise on HotCopper. Created with Sketch. Folks say we are pioneers of craft ice cream in Victoria. . Last edited by jellyroll: 27/02/23. Created with Sketch. ASX - Day TradingCreated with Sketch. Charts. Also took placement stock @$1. . 0. Update - Notification regarding unquoted securities - IXC. ASX - By Stock. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. ASX - By Stock. A new thread to put trading comments / reasoning / opinions in. 2 Upvote. , page-2. Can&apos;t see how this doesn&apos;t push up soon, page-508. Proposed Capital Return to Shareholders of $14. 1950. US data averaged $2314 per person in direct medical care, the total average direct cost per IIH admission was 4x that or $9256. GW Ixc once again showing why you are the best mgmt team on the ASX . ASX - Day Trading. ASX - By Stock. IXC (ASX) Ann: Trading Halt - HotCopper. ASX - General. . The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. ASX - General. 147,415. Created with Sketch. Yes its risky of course, like all the asx speculative stocks out there, but considering what NEU has done, what CUV has done (both billion dollar companies now), why wouldnt you. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. The company can always acquire something new or do some capital returns. HotCopper has news, discussion, prices and market data on IXUP LIMITED. A rolling snowball gathers snow as it falls down the hill . ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. Liked by Jackie Cox-Ziegler, CPHR. Created with Sketch. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. a shell trading below cash backing, ripe. Friday we moved 55% off 690k volume. 76 (-1. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. ASX - Day TradingHere's a very good opportunity for people in Sydney. ASX - Short Term Trading. 375,000. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. ASX - Day TradingAnother day…another approval. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. Currency in USD 38. Created with Sketch. Market Cap $16. Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. Ceasing to be a substantial holder. I guess that&amp;apos;s why retail performs so poorly on average, so many think they are long term investors but can&amp;apos;t hold onto their shares for more. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. ASX - Day TradingHi all, I would like to preface the below summary written prior to the research links as being a heavily simplified summary of the company and the. Created with Sketch. gov and there is lots of good information about the trial. Management have earmarked this a significant milestone - given they previously tied it to performance. , page-4. Cold Comfort Ice Cream Company, Victoria, British Columbia. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. 3. Slow and steady with IXC. Created with Sketch. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. LoginJoin Now. ASX - Day Tradingis invex releasing 2. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. Plans & Pricing. 05. ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. ASX - Day TradingChange in substantial holding. here (arrow) per the NEU chart Close now to breaking trend and establishing a more upper trend into results IMO IXC Price at posting: 40. Created with Sketch. ASX - Day TradingSomeone bought $500 stock today at 44 cents. Get the edge as an investor: Subscribe to our daily newsletter for EXCLUSIVE insights into HotCopper!. Latest Posts. Trading HaltDCF Valuation: IXC Intrinsic Value of $6. Latest Posts. IAMIncome Asset Management to boost bond sales through partnership with Netwealth. The announcement was certainly a setback but we're not dead in. Created with Sketch. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. . is there any news release, or SP increasing due to only the market showing interestInvex Receives UK Approval to Commence Phase III TrialInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Latest Posts. com. . IXC Price at posting. *Close price adjusted for splits. . ASX - Short Term Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Spot on - filled the 1. Share Would anyone know whether the 28c cash backing strips out all of the options listed in the notice? or is it included and they will fall away on strike dates?wonder if the GLP-1 agonist referred to in this media release. Market . Wouldn’t surprised me if they turn this company into something else if he keeps buyingCreated with Sketch. , page-5. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Invex Therapeutics Ltd. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. Join the HotCopper ASX share market. . IXC Price at posting: 79. These are 2007 numbers. 6 Upvote. Created with Sketch. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. ASX - Short Term Trading. Learn how it impacts everything we do. Appendix 4E and Annual Report, page-3. Created with Sketch. 20. I think having this out we can discuss on the way. . . ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. 1956773. Notice of Investor Call and Presentation, page-3. Created with Sketch. . Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. It's essentially a cashed up shell company right now it. Invex Receives Approval for Paediatric Plan from the EMA, page-3. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. Last research or update on this I listened to was by FiftyOneCapital. Latest Posts. ASX - General. ASX - By Stock. ASX - Day TradingCreated with Sketch. . 0. Below is the broker data for IXC November to. 91%) As of 03:35PM EST. **Close price adjusted for splits and dividend and/or capital gain distributions. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Mernova, a subsidiary of Melodiol Global Health (ASX:ME1), is on track to achieve its highest ever monthly sales, with revenues expected to reach A$891,944 in October 2023. . Latest Posts. 392 10/12/19 20:43 Post #: 41898691 Share @FullMoonFever Another chart request if you are up for it please thanks in advance IXC Valuation Report MST. Market . . . Created with Sketch. . Discover historical prices for IXC. Latest Posts Forums iShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Some people like to gamble on stocks, others invest. Created with Sketch. , page-3. Market . ASX - Day TradingI bought some today at 44. Latest Posts. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. But the market volume was very low, which points to a lack of interest, the long horizons of biotech, lack of publicising or Notification of cessation of securities - IXC. Share 14 mill MC 22 mill cash Like I said they might have gotten rid of Jason and Alex to streamline costs, smartest thing to do is JV with some large pharma let them run trials we get 40% royalty and they get 60% of drug (sell it to them). 0. Webinvest Pty Ltd<Olsb Unit A/C>. Created with Sketch. . 0 Great. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. Latest Posts. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumFound this article a while back although raises some decent points. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. Probably been disappointed like all of us Created with Sketch. Australia's largest stock trading and investment forum Australia's #1 stock forumCreated with Sketch. , page-2. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. This was roughly 50/50 between lost wages and direct medical costs. . ASX - By Stock. . ASX - Short Term Trading. AX stock on Yahoo Finance. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. , page-2. So your thesis is right on a long time time frame. 0. When can we expect some update or. Information. pause in tradingHere we go! AU and UK sites activated for immediate recruitment. Join the HotCopper ASX share market forum today for free. 0 Great analysis. is there any news release, or SP increasing due to only the market showing interest, page-2. Target our investor community with our suite of Hotcopper Advertising opportunities. . . ASX - General. Just another way to saying that we've got Patient 1 out of 240. ASX - Day Trading. Created with Sketch. Target our investor community with our suite of Hotcopper Advertising opportunities. ASX - Day TradingInitial FDA and EMA Advice on Presendin Development, page-2. , page-3. . Top 20 remains holding 58% compared to 58. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. 26 area could be wrong and it could go for example to $3. . Latest Posts. The Chart: An Opportunity at these Levels?Timeline Annotations of the IXC Chart Story Thus Far- IXC IPO'd in mid 2019 with Phase II data due Mid 2020,. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. Created with Sketch. 79 -0. Charts. . Charts. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Australian finance news, stock quotes, currency information and blogs0. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. 1950. Join the HotCopper ASX share market forum today for free. Forums. Latest Posts. ASX - By Stock. *Close price adjusted for splits. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. . . . ASX - Day Trading. 8M ! Add to my watchlist. . Been. ASX - General. RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. 30 Haven’t supported share price since then on market . To work out how much Presendin is worth, we can look at the costs of IIH to the American health care system. Created with Sketch. . Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. . . Created with Sketch. IXC Price at posting: 44. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. , page-136. . ASX - By Stock. Forex. Withdrawal of AGM Resolutions, page-2. The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. , page-188. ASX - General. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. Share I've got no issues with it. , page-5. 0¢ Sentiment: Buy Disclosure: Held. Forums. ASX - Short Term Trading. 0. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. ASX - By Stock. IXC Valuation Report MST. ASX - By Stock. Update - Notification regarding unquoted securities - IXC. Here come the vultures. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. Trading HaltIXC Valuation Report MST. ASX - By Stock. 50%. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. Appendix 4C - quarterly* or having a go at doing so, page-30. ASX - By Stock. ASX - By Stock. Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Contrast that to data from Wales in 2017 which suggests that. Join HotCopper today. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. Created with Sketch. IXC Valuation Report MST. Theres alot of breakdowns above that are yet to be backtested. Forums. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. Last updated 10. Some people like to gamble on stocks, others invest. Market Cap $102. Market . A neurosurgeon from Mercer Island and a noted mountaineer from Spokane, Washington, were killed on February 4, 1986, when. Trading HaltIXC Valuation Report MST. I'm doing my bit lolRecent success of NEU and ALA just goes to show there is money floating around, all IXC needs is a. , page-3. , page-17. ASX - General. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. Created with Sketch. IXC Valuation Report MST. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-7. Charts. Created with Sketch. ASX - Short Term Trading. Market . I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. Created with Sketch. IXC Price at posting: 45. , page-3. Created with Sketch. 147,415. 1950. , page-32. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 10 cents a week and we will be at $2 plus in no time. ASX - By Stock. ASX - Short Term Trading. Probably been disappointed like all of usCreated with Sketch. Date of AGM and Closing Date for Director NominationsCD is on the money once again, page-195. 5mill options have been issued at a strike price of $1 First lot 250k to a soph. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. ASX - Short Term Trading. Initial FDA and EMA Advice on Presendin Development, page-3. Latest Posts. Very impressive. Invex Granted Key European Patent for Exenatide, page-2. Very tempted to buy them back today at 19c. Report to HotCopper and itll be the end of it, cheers. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. Advertise on HotCopper. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. Latest Posts. Only took that large seller to sell, now liquidity has dried up and. ASX - Day Trading0. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. Report Created with Sketch. Both approaches can work, but it is not wise to confuse the two. Created with Sketch.